Status:
UNKNOWN
Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease
Lead Sponsor:
University Hospital, Angers
Conditions:
Non-alcoholic Fatty Liver Disease
Sleep Apnea, Obstructive
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Obstructive sleep apnea (OSA) and nonalcoholic fatty liver disease (NAFLD) are frequently encountered in patients with metabolic syndrome (MS). Several data suggest that OSA per se could be a risk fac...
Eligibility Criteria
Inclusion
- Suspected NAFLD requiring per-cutaneous liver biopsy
Exclusion
- Other than NAFLD liver disease
- Previously diagnosed or treated OSA
- Excessive alcohol consumption (\>220 gr/week for men, \>140 gr/week for women)
- Pregnancy
- Surgical treatment for obesity past history
Key Trial Info
Start Date :
December 14 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 14 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03373643
Start Date
December 14 2017
End Date
March 14 2020
Last Update
January 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Angers
Angers, Please Select, France, 49100